Anaerostipes hadrus

Information

Microbe Identification

Anaerostipes hadrus

Microbe id: PMDBM2020369
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Anaerostipes hadrus [649756]
Taxonomy Genus: Anaerostipes [207244]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Anaerostipes hadrus

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clusterFumarateFumarate to succinatePMID: 28049145
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
PFOR II pathway B. thetaiotaomicronPyruvatePFOR II pathwayPMID: 32301184
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Anaerostipes hadrus


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RRE-containingPMID: 34019648
Unclassified gene clustern.a.RanthipeptidePMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Anaerostipes hadrus distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Anaerostipes hadrus in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Anaerostipes hadrus

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.45170376788435mNGS
Kidney Failure, Chronic PRJNA449784🔗3.61593819616178mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.88024120191398mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.82521506487942mNGS
Hypertension PRJNA509999🔗3.25346595270829mNGS
Hypertension PRJNA509999🔗3.29449942698767mNGS
Arthritis, Juvenile PRJNA562467🔗-3.4454119013112616S
Diabetes Mellitus, Type 2 PRJNA661673🔗-4.041620184689516S
Diabetes Mellitus, Type 2 PRJNA588353🔗-3.4303582983852516S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-3.8714206572571716S
Coronary Disease PRJNA818062🔗3.42543540308783mNGS
Coronary Disease PRJNA818062🔗3.59544383541554mNGS
Diarrhea PRJNA317326🔗-3.93541024450416S
Dwarfism PRJNA808649🔗4.18109438086461mNGS
Dwarfism PRJNA808649🔗4.18869206135746mNGS
Colorectal Neoplasms PRJDB11845🔗-3.8667524666661116S
Colorectal Neoplasms PRJNA284542🔗-3.6397177694407616S
Colorectal Neoplasms PRJEB46665🔗-3.6264163159825416S
Colorectal Neoplasms PRJNA1138893🔗-3.4563386387745mNGS
Colorectal Neoplasms PRJNA888860🔗-3.45069300953242mNGS
Colorectal Neoplasms PRJNA1138893🔗-3.42773953584316mNGS
Colorectal Neoplasms PRJNA888860🔗-3.39440174246689mNGS
Colorectal Neoplasms PRJNA464414🔗-3.2291186134996416S
Colorectal Neoplasms PRJNA763023🔗-3.0976816855624mNGS
Colorectal Neoplasms PRJNA763023🔗-3.06134175197549mNGS
Colorectal Neoplasms PRJNA1167935🔗-2.97601210421188mNGS
Colorectal Neoplasms PRJNA1167935🔗-2.97101081667609mNGS
Colorectal Neoplasms PRJNA1050885🔗4.44406426417196mNGS
Colorectal Neoplasms PRJNA1050885🔗4.48747118192829mNGS
Gastrointestinal Diseases PRJNA760529🔗-3.7037286292354916S
Mental Disorders PRJNA278793🔗-2.7858742680922516S
Colitis, Ulcerative PRJNA917086🔗-4.3015282048340316S
Colitis, Ulcerative PRJEB42155🔗-3.83817179432652mNGS
Colitis, Ulcerative PRJNA804422🔗-3.8170774092283616S
Colitis, Ulcerative PRJNA398089🔗3.28748087254392mNGS
Colitis, Ulcerative PRJNA398089🔗3.36585476790023mNGS
Colitis, Ulcerative PRJEB6172🔗5.2416047555917616S
Spinal Cord Injuries PRJNA861246🔗-3.5193594016450916S
Macular Degeneration PRJNA799475🔗-4.2044812932941316S
Carcinoma, Hepatocellular PRJNA932948🔗-4.05505867272617mNGS
Carcinoma, Hepatocellular PRJNA932948🔗-4.05007028054834mNGS
Celiac Disease PRJNA890948🔗-3.9272626017412316S
Caliciviridae Infections PRJNA788674🔗-4.4689717090754816S
Hepatolenticular Degeneration PRJNA1038771🔗-3.6074811505637816S
Osteoporosis PRJNA565497🔗2.9194195326076816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-2.7843276166707816S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-3.8628365914436216S
Hidradenitis Suppurativa PRJEB43835🔗-4.293006594433216S
Tic Disorders PRJNA780788🔗4.0431619060755316S
Crohn Disease PRJNA938107🔗-4.1194824826939816S
Crohn Disease PRJNA917086🔗-4.106217943274616S
Crohn Disease PRJNA820056🔗-3.5463196761616316S
Crohn Disease PRJNA993675🔗3.27712883962825mNGS
Crohn Disease PRJNA993675🔗3.28871714379507mNGS
Crohn Disease PRJNA1156939🔗3.3207720368031816S
Crohn Disease PRJNA793776🔗3.34636449230524mNGS
Crohn Disease PRJNA793776🔗3.45049348775848mNGS
Psoriasis PRJNA574485🔗-3.999100202372516S
Polycystic Ovary Syndrome PRJNA530971🔗3.26325039889709mNGS
Polycystic Ovary Syndrome PRJNA530971🔗3.27078065983121mNGS
Schistosomiasis haematobia PRJNA526732🔗-2.6946791680583116S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗-3.15224981654242mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗-3.15021516726841mNGS
Cholestasis PRJNA478781🔗-3.9061564315871616S
Premenstrual Syndrome PRJDB13374🔗4.0473217168262716S
Appendicitis PRJDB8606🔗-3.5023753778741716S
Arthritis, Rheumatoid PRJNA896336🔗3.93561343092804mNGS
Arthritis, Rheumatoid PRJNA896336🔗4.02560731084496mNGS
Anorexia PRJNA674716🔗-3.85133078616798mNGS
Anorexia PRJNA674716🔗-3.76541748223245mNGS
Cholangiocarcinoma PRJNA932948🔗-4.13518756519801mNGS
Cholangiocarcinoma PRJNA932948🔗-4.10598315076792mNGS
Flatulence PRJNA206071🔗3.9457056173304916S
Anorexia Nervosa PRJEB11199🔗4.2023825430515516S
Neuroblastoma PRJNA716780🔗-3.7275763875288mNGS
Neuroblastoma PRJNA716780🔗-3.68020387213882mNGS
Neuroblastoma PRJEB63351🔗-3.48316117915223mNGS
Neuroblastoma PRJEB63351🔗-3.45400457094772mNGS
Hematologic Neoplasms PRJNA777832🔗-3.9783740860640616S
Irritable Bowel Syndrome PRJNA682378🔗-3.2730929759363816S
Peutz-Jeghers Syndrome PRJNA905444🔗-4.04663412464339mNGS
Peutz-Jeghers Syndrome PRJNA905444🔗-4.04152111925631mNGS
Peutz-Jeghers Syndrome PRJNA545597🔗3.6047180187092516S
Gastroesophageal Reflux PRJNA993632🔗-4.38237532541475mNGS
Gastroesophageal Reflux PRJNA993632🔗-4.36913252006004mNGS
Clostridium Infections PRJNA648321🔗-3.04647897936237mNGS
Amyotrophic Lateral Sclerosis PRJEB32767🔗-3.92029180526767mNGS
Amyotrophic Lateral Sclerosis PRJEB32767🔗-3.90197160333361mNGS
Diabetes, Gestational PRJNA556764🔗3.7133458488051116S
Pancreatic Neoplasms PRJNA665854🔗-4.53311444219985mNGS
Pancreatic Neoplasms PRJNA665854🔗-4.35927963685878mNGS
Cholelithiasis PRJNA999028🔗-4.05799962488893mNGS
Cholelithiasis PRJNA999028🔗-3.99158249074898mNGS
Alzheimer Disease PRJEB59009🔗-3.101649766864416S
Liver Cirrhosis PRJNA861246🔗-3.4819702274867916S
Obesity PRJNA794317🔗-3.3204704507706316S
Obesity PRJNA1125836🔗4.22430223956032mNGS
Obesity PRJNA1125836🔗4.2312957273998mNGS
Hypercholesterolemia PRJNA842179🔗-3.0306250191382816S
HIV Infections PRJDB11949🔗-3.787815507913216S
HIV Infections PRJNA810567🔗-3.5418578543458216S
Autism Spectrum Disorder PRJNA746094🔗4.5670539927632616S
Inflammatory Bowel Diseases PRJNA511372🔗-4.60170132962085mNGS
Inflammatory Bowel Diseases PRJNA511372🔗-4.54462953544735mNGS
Renal Insufficiency, Chronic PRJNA562327🔗-3.4719694414066616S
Malaria PRJNA642859🔗-3.6042567632517116S
Fibromyalgia PRJEB80379🔗-4.41419447810218mNGS
Fibromyalgia PRJEB80379🔗-4.40925873455396mNGS
Breast Neoplasms PRJNA658160🔗2.8103669044484816S
COVID-19 PRJNA624223🔗-4.33003234232523mNGS
COVID-19 PRJNA624223🔗-4.28763356017305mNGS
COVID-19 PRJNA769052🔗-4.2479217275320316S
COVID-19 PRJDB13214🔗-3.84757072002663mNGS
COVID-19 PRJDB13214🔗-3.79123212610658mNGS
COVID-19 PRJNA678695🔗-3.7454363099659216S
COVID-19 PRJNA907010🔗4.4733584205340516S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Anaerostipes hadrus



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Anaerostipes hadrus



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Anaerostipes hadrus

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Anaerostipes_hadrus_ERR1022288 Download
2Anaerostipes_hadrus_ERR1022326 Download
3Anaerostipes_hadrus_ERR1022376 Download
4Anaerostipes_hadrus_ERR1022422 Download
5Anaerostipes_hadrus_ERR1022423 Download
6Anaerostipes_hadrus_ERR1022473 Download
7Anaerostipes_hadrus_ERR2221197 Download
8Anaerostipes_hadrus_ERR2221199 Download
9Anaerostipes_hadrus_DSM_3319 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Anaerostipes hadrus


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Anaerostipes hadrus



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Anaerostipes hadrus

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Anaerostipes hadrus

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Anaerostipes hadrus

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
1Anaerostipes_hadrus_DSM_3319 View

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Anaerostipes hadrus



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Anaerostipes hadrus


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Anaerostipes hadrus


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?